TNFa microsatellite polymorphism modulates the risk of type 1 diabetes in the Belgian population, independent of HLA-DQ

Human Immunology

Volumn 68, Issue 8, 2007, Pages 690-697

  Aminkeng, Folefac ^a   Van Autreve, Jan E ^a   Koeleman, Bobby P C ^b   Quartier, Erik ^a   Van Schravendijk, Chris ^a   Gorus, Frans K ^a   Van der Auwera, Bart J R ^a  

^a DIABETES RESEARCH CENTER   (Belgium)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

HLA; Microsatellite; SNP; Tumor necrosis factor ; Type 1 diabetes

Indexed keywords

HLA DQ ANTIGEN; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ALLELE; ARTICLE; BELGIUM; CONTROLLED STUDY; DIABETOGENESIS; FEMALE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HLA SYSTEM; HUMAN; IMMUNOGENETICS; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE MARKER; ONSET AGE; POPULATION RISK; PRIORITY JOURNAL; PROMOTER REGION; RISK ASSESSMENT; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; ALLELES; BELGIUM; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; MALE; MICROSATELLITE REPEATS; POLYMORPHISM, SINGLE NUCLEOTIDE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34547206053     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2007.05.001     Document Type: Article

References (53)

1. Cucca F., Lampis R., Congia M., Angius E., Nutland S., Bain S., et al. A correlation between the relative predisposition of MHC class II alleles to type 1 diabetes and the structure of their proteins. Hum Mol Genet 10 (2001) 2025
2. Van der Auwera B.J., Schuit F.C., Weets I., Ivens A., Van Autreve J.E., Gorus F.K., et al. Relative and absolute HLA-DQA1-DQB1-linked risk for developing type 1 diabetes before 40 years of age in the Belgian population: Implications for future prevention studies. Hum Immunol 63 (2002) 40
3. Van der Auwera B.J., Heimberg H., Schrevens F., Van Waeyenberge F., Flament J., and Schuit F.C. 5′ Insulin gene polymorphism confers risk to IDDM independently of HLA class II susceptibility. Diabetes 42 (1993) 851
4. Barratt B.J., Payne F., Lowe C.E., Hermann R., Healy B.C., Harold D., et al. Remapping the insulin gene/IDDM2 locus in type 1 diabetes. Diabetes 53 (2004) 1884
5. Nisticó L., Buzzetti R., Pritchard L.E., Van der Auwera B., Giovannini C., Bosi E., et al. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Hum Mol Genet 5 (1996) 1075
6. Ueda H., Howson J.M., Esposito L., Heward J., Snook H., Chamberlain G., et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423 (2003) 506
7. Bottini N., Musumeci L., Alonso A., Rahmouni S., Nika K., Rostamkhani M., et al. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet 36 (2004) 337
8. Vella A., Cooper J.D., Lowe C.E., Walker N., Nutland S., Widmer B., et al. Localization of a type 1 diabetes locus in the IL2RA/CD25 region by use of tag single-nucleotide polymorphisms. Am J Hum Genet 76 (2005) 773
9. Smyth D.J., Cooper J.D., Bailey R., Field S., Burren O., Smink L.J., et al. A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region. Nat Genet 38 (2006) 617
10. Risch N. Assessing the role of HLA-linked and unlinked determinants of disease. Am J Hum Genet 40 (1987) 1
11. Noble J.A., Valdes A.M., Cook M., Klitz W., Thomson G., and Erlich H.A. The role of HLA class II genes in insulin-dependent diabetes mellitus: Molecular analysis of 180 Caucasian, multiplex families. Am J Hum Genet 59 (1996) 1134
12. Lambert A.P., Gillespie K.M., Thomson G., Cordell H.J., Todd J.A., Gale E.A., et al. Absolute risk of childhood-onset type 1 diabetes defined by human leukocyte antigen class II genotype: A population-based study in the United Kingdom. J Clin Endocrinol Metab 89 (2004) 4037
13. Bouqbis L., Akhayat O., Garchon H.J., Calafell F., and Izaabel H. TNFA-TNFB haplotypes modify susceptibility to type I diabetes mellitus independently of HLA class II in a Moroccan population. Tissue Antigens 61 (2003) 72
14. Moghaddam P.H., Zwinderman A.H., de Knijff P., Roep B.O., Schipper R.F., Van der Auwera B., et al. TNFa microsatellite polymorphism modulates the risk of IDDM in Caucasians with the high-risk genotype HLA DQA1*0501-DQB1*0201/DQA1*0301-DQB1*0302. Diabetes 46 (1997) 1514
15. Van Autreve J.E., Koeleman B.P., Quartier E., Aminkeng F., Weets I., Gorus F.K., et al. MICA is associated with type 1 diabetes in the Belgian population, independent of HLA-DQ. Hum Immunol 67 (2006) 94
16. Zavattari P., Lampis R., Mulargia A., Angius E., Todd J.A., and Cucca F. Confirmation of the DRB1-DQB1 loci as the major component of IDDM1 in the isolated founder population of Sardinia. Hum Mol Genet 9 (2000) 2967
17. Udalova I.A., Nedospasov S.A., Webb G.C., Chaplin D.D., and Turetskaya R.L. Highly informative typing of the human TNF locus using six adjacent polymorphic markers. Genomics 16 (1993) 180
18. Tsukamoto K., Ohta N., Shirai Y., and Emi M. A highly polymorphic CA repeat marker at the human tumor necrosis factor alpha (TNFA alpha) locus. J Hum Genet 43 (1998) 278
19. Nedwin G.E., Naylor S.L., Sakaguchi A.Y., Smith D., Jarrett-Nedwin J., Pennica D., et al. Human lymphotoxin and tumor necrosis factor genes: Structure, homology and chromosomal localization. Nucleic Acids Res 13 (1985) 6361
20. Rodriguez-Carreon A.A., Zuniga J., Hernandez-Pacheco G., Rodriguez-Perez J.M., Perez-Hernandez N., Montes de Oca J.V., et al. Tumor necrosis factor-alpha -308 promoter polymorphism contributes independently to HLA alleles in the severity of rheumatoid arthritis in Mexicans. J Autoimmun 24 (2005) 63
21. Aguillon J.C., Cruzat A., Cuenca J., and Cuchacovich M. [Tumor necrosis factor alpha genetic polymorphism as a risk factor in disease]. Rev Med Chil 130 (2002) 1043
22. Wachlin G., Augstein P., Schroder D., Kuttler B., Kloting I., Heinke P., et al. IL-1beta, IFN-gamma and TNF-alpha increase vulnerability of pancreatic beta cells to autoimmune destruction. J Autoimmun 20 (2003) 303
23. Hajeer A.H., and Hutchinson I.V. Influence of TNFα gene polymorphisms on TNFα production and disease. Hum Immunol 62 (2001) 1191
24. Pociot F., Briant L., Jongeneel C.V., Mol̈vig J., Worsaae H., Abbal M., et al. Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNA-α and TNF-β by human mononuclear cells: A possible link to insulin-dependent diabetes mellitus. Eur J Immunol 23 (1993) 224-231
25. Weets I., Van Autreve J., Van der Auwera B., Schuit F., Du Caju M., Decochez K., et al. Male-to-female excess in diabetes diagnosed in early adulthood is not specific for the immune-mediated form nor is it HLA-DQ restricted: Possible relation to increased body mass index. Diabetologia 44 (2001) 40
26. Heimberg H., Nagy Z.P., Somers G., De Leeuw I., and Schuit F.C. Complementation of HLA-DQA and -DQB genes confers susceptibility and protection to insulin-dependent diabetes mellitus. Hum Immunol 33 (1992) 10
27. Livak K.J. Allelic discrimination using fluorogenic probes and the 5′ nuclease assay. Genet Anal 14 (1999) 143
28. Obayashi H., Nakamura N., Fukui M., Tegoshi H., Fujii M., Ogata M., et al. Influence of TNF microsatellite polymorphisms (TNFa) on age-at-onset of insulin-dependent diabetes mellitus. Hum Immunol 60 (1999) 974
29. Vandewalle C.L., Decraene T., Schuit F.C., De Leeuw I.H., Pipeleers D.G., Gorus F., et al. Insulin autoantibodies and high titre islet cell antibodies are preferentially associated with the HLA DQA1*0301-DQB1*0302 haplotype at clinical onset of type 1 (insulin-dependent) diabetes mellitus before age 10 years, but not at onset between age 10 and 40 years. Diabetologia 36 (1993) 1155
30. Vandewalle C.L., Falorni A., Lernmark Å., Goubert P., Dorchy H., Coucke W., et al. Associations of GAD65- and IA-2-autoantibodies with genetic risk markers in new-onset IDDM patients and their siblings. Diabetes Care 20 (1997) 1547
31. Decochez K., Tits J., Coolens J.L., Van Gaal L., Krzentowski G., Winnock F., et al. High frequency of persisting or increasing islet-specific autoantibody levels after diagnosis of type 1 diabetes presenting before 40 years of age. The Belgian Diabetes Registry. Diabetes Care 23 (2000) 838
32. Koeleman B.P., Dudbridge F., Cordell H.J., and Todd J.A. Adaptation of the extended transmission/disequilibrium test to distinguish disease associations of multiple loci: The Conditional Extended Transmission/Disequilibrium Test. Ann Hum Genet 64 (2000) 207
33. Dudbridge F. Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 25 (2003) 115
34. Woolf B. On estimating the relation between blood group and disease. Ann Hum Genet 19 (1955) 251
35. Undlien D.E., Kockum I., Rønningen K.S., Lowe R., Saanjeevi C.B., Graham J., et al. HLA associations in type 1 diabetes among patients not carrying high-risk DR3-DQ2 or DR4-DQ8 haplotypes. Tissue Antigens 54 (1999) 543
36. Kroeger K.M., Carville K.S., and Abraham L.J. The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Mol Immunol 34 (1997) 391
37. Wilson A.G., Symons J.A., McDowell T.L., McDevitt H.O., and Duff G.W. Effects of a polymorphism in the human tumor necrosis factor α promoter on transcriptional activation. Proc Natl Acad Sci U S A 94 (1997) 3195
38. Louis E., Franchimont D., Piron A., Gevaert Y., Schaaf-Lafontaine N., Roland S., et al. Tumour necrosis factor (TNF) gene polymorphism influences TNF-α production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clin Exp Immunol 113 (1998) 401
39. Obayashi H., Nakamura N., Fukui M., Tegoshi H., Fujii M., Ogata M., et al. Influence of TNF microsatellite polymorphisms (TNFa) on age-at-onset of insulin-dependent diabetes mellitus. Hum Immunol 60 (1999) 974
40. Torn C., Hillman M., Sanjeevi C.B., and Landin-Olsson M. Polymorphisms of TNF microsatellite marker a and HLA-DR-DQ in diabetes mellitus-a study in 609 Swedish subjects. Hum Immunol 67 (2006) 527
41. Deng G.Y., Maclaren N.K., Huang H.S., Zhang L.P., and She J.X. No primary association between the 308 polymorphism in the tumor necrosis factor alpha promoter region and insulin-dependent diabetes mellitus. Hum Immunol 45 (1996) 137
42. Cox A., Gonzalez A.M., Wilson A.G., Wilson R.M., Ward J.D., Artlett C.M., et al. Comparative analysis of the genetic associations of HLA-DR3 and tumour necrosis factor alpha with human IDDM. Diabetologia 37 (1994) 500
43. Pociot F., Wilson A.G., Nerup J., and Duff G.W. No independent association between a tumor necrosis factor-alpha promotor region polymorphism and insulin-dependent diabetes mellitus. Eur J Immunol 23 (1993) 3050
44. Yunis E.J., Larsen C.E., Fernandez-Vina M., Awdeh Z.L., Romero T., Hansen J.A., et al. Inheritable variable sizes of DNA stretches in the human MHC: Conserved extended haplotypes and their fragments or blocks. Tissue Antigens 62 (2003) 1
45. Hajeer A.H., and Hutchinson I.V. TNF-alpha gene polymorphism: Clinical and biological implications. Microsc Res Tech 50 (2000) 216
46. Monos D.S., Kamoun M., Udalova I.A., Csanky E., Cizman B., Turetskaya R.L., et al. Genetic polymorphism of the human tumor necrosis factor region in insulin-dependent diabetes mellitus-linkage disequilibrium of TNFab microsatellite alleles with HLA haplotypes. Hum Immunol 44 (1995) 70-79
47. Johansson S., Lie B.A., Todd J.A., Pociot F., Nerup J., Cambon-Thomsen A., et al. Evidence of at least two type 1 diabetes susceptibility genes in the HLA complex distinct from HLA-DQB1, -DQA1 and -DRB1. Genes Immun 4 (2003) 46
48. Johansson S., Lie B.A., Pociot F., Nerup J., Cambon-Thomsen A., Kockum I., et al. HLA associations in type 1 diabetes: DPB1 alleles may act as markers of other HLA-complex susceptibility genes. Tissue Antigens 61 (2003) 344
49. Shtauvere-Brameus A., Dabadghao P., Rumba I., and Sanjeevi C.B. Tumor necrosis factor-alpha allele 2 shows an association with insulin-dependent diabetes mellitus in Latvians. Ann N Y Acad Sci 958 (2002) 357
50. Noble J.A., Valdes A.M., Lane J.A., Green A.E., and Erlich H.A. Linkage disequilibrium with predisposing DR3 haplotypes accounts for apparent effects of tumor necrosis factor and lymphotoxin-alpha polymorphisms on type 1 diabetes susceptibility. Hum Immunol 67 (2006) 999
51. Price P., Bolitho P., Jaye A., Glasson M., Yindom L.M., Sirugo G., et al. A Gambian TNF haplotype matches the European HLA-A1,B8,DR3 and Chinese HLA-A33,B58,DR3 haplotypes. Tissue Antigens 62 (2003) 72-75
52. Koeleman B.P., Herr M.H., Zavattari P., Dudbridge F., March R., Campbell D., et al. Conditional ETDT analysis of the human leukocyte antigen region in type 1 diabetes. Ann Hum Genet 64 (2000) 215-221
53. Gambelunghe G., Ghaderi M., Cosentino A., Falorni A., Brunetti P., Falorni A., et al. Association of MHC class I chain-related A (MIC-A) gene polymorphism with type I diabetes. Diabetologia 43 (2000) 507